FcεRIγ reinforces double-negative T cell-mediated antibody-dependent cellular cytotoxicity against tumor cells
Journal of Molecular Cell Biology · 2026
DOI: 10.1093/jmcb/mjaf059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2026. Verfasst von Shuai Shao und 13 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China. Hauptthemen laut MEDLINE: Antibody-Dependent Cell Cytotoxicity, Receptors, IgG, T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, R&D Program of Beijing Municipal Education Commission, Chinese Institutes for Medical Research, Beijing.
Abstract (Originalsprache)
Double-negative T (DNT) cells (TCRαβ+CD4−CD8−NK1.1−/CD56−) exhibit strong tumor-killing capabilities. Our single-cell transcriptome analysis has revealed high Fcer1g expression in DNT cells, but its role in tumor immunity remains unclear. In this study, we demonstrated that IgG1 stimulation significantly upregulated IgG Fc receptors and cytotoxic molecules in DNT cells, enhancing their cytotoxicity against MC38 tumor cells in vitro. FcεRIγ-deficient DNT cells failed to respond effectively to IgG1 stimulation. Inhibiting the downstream spleen tyrosine kinase (Syk) of FcεRIγ reduced cytotoxicity of DNT cells and phosphorylation levels of molecules such as AKT and NF-κB. In a subcutaneous tumor model, combined treatment with DNT cells and tumor-specific antibodies more effectively inhibited tumor growth compared to DNT cells alone, while FcεRIγ-deficient DNT cells combined with antibodies showed no significant difference in efficacy compared to DNT cells alone, suggesting that DNT cells enhance tumor cell killing via FcεRIγ-mediated antibody-dependent cellular cytotoxicity (ADCC). These results indicate that DNT cells mediate antitumor ADCC effects through high FcεRIγ expression. Binding of IgG1 to FcεRIγ activates the FcεRIγ/Syk/AKT/NF-κB pathway, consequently enhancing tumor cell killing. Thus, DNT cells may play a significant role in cancer immunity, providing a basis for novel immune cell and antibody combination therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery Department, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
- Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing Clinical Research Institute and Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
- National Clinical Research Center for Digestive Disease, Beijing 100050, China.
- State Key Lab of Digestive Health, Beijing 100050, China.
- Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
- Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
ORCID-Profile: Shuai Shao, Mingyang Li, Dan Tian
Förderung
- National Natural Science Foundation of China
- R&D Program of Beijing Municipal Education Commission
- Chinese Institutes for Medical Research, Beijing
- Beijing Nova Program
- China Postdoctoral Science Foundation
- Beijing Postdoctoral Research Foundation
Zitieren
APA
Shao, S., Han, X., Zhang, T., Yang, L., Li, M., Zhang, Z., Du, X., Jin, H., Wang, S., Yang, Y., Zhang, Z., Sun, G., Zhang, D., & Tian, D. (2026). FcεRIγ reinforces double-negative T cell-mediated antibody-dependent cellular cytotoxicity against tumor cells. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjaf059
Vancouver
Shao S, Han X, Zhang T, Yang L, Li M, Zhang Z, et al. FcεRIγ reinforces double-negative T cell-mediated antibody-dependent cellular cytotoxicity against tumor cells. Journal of Molecular Cell Biology. 2026. doi:10.1093/jmcb/mjaf059
BibTeX
@article{Shao2026,
author = {Shao, Shuai and Han, Xiaotong and Zhang, Tianzhen and Yang, Lu and Li, Mingyang and Zhang, Zihan and Du, Xiaonan and Jin, Hua and Wang, Songlin and Yang, Yingchi and Zhang, Zhongtao and Sun, Guangyong and Zhang, Dong and Tian, Dan},
title = {FcεRIγ reinforces double-negative T cell-mediated antibody-dependent cellular cytotoxicity against tumor cells},
journal = {Journal of Molecular Cell Biology},
year = {2026},
doi = {10.1093/jmcb/mjaf059}
}
EUVIMED